1. Home
  2. CYTK vs NICE Comparison

CYTK vs NICE Comparison

Compare CYTK & NICE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

HOLD

Current Price

$63.34

Market Cap

8.0B

Sector

Health Care

ML Signal

HOLD

Logo NICE Ltd

NICE

NICE Ltd

HOLD

Current Price

$106.53

Market Cap

7.1B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
CYTK
NICE
Founded
1997
1986
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
8.0B
7.1B
IPO Year
2004
1996

Fundamental Metrics

Financial Performance
Metric
CYTK
NICE
Price
$63.34
$106.53
Analyst Decision
Strong Buy
Buy
Analyst Count
16
13
Target Price
$84.81
$162.31
AVG Volume (30 Days)
1.8M
751.5K
Earning Date
02-26-2026
02-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
35.79
EPS
N/A
8.79
Revenue
$87,211,000.00
$2,880,503,000.00
Revenue This Year
$341.94
$9.57
Revenue Next Year
$75.44
$8.07
P/E Ratio
N/A
$11.76
Revenue Growth
2609.26
9.24
52 Week Low
$29.31
$99.00
52 Week High
$70.98
$180.61

Technical Indicators

Market Signals
Indicator
CYTK
NICE
Relative Strength Index (RSI) 49.19 34.72
Support Level $62.13 $106.00
Resistance Level $65.88 $117.21
Average True Range (ATR) 2.59 3.73
MACD 0.07 -0.83
Stochastic Oscillator 54.84 6.79

Price Performance

Historical Comparison
CYTK
NICE

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About NICE NICE Ltd

Nice is an enterprise software company that serves the customer engagement and financial crime and compliance markets. Software is deployed primarily on the cloud, but also on premises. Within customer engagement, Nice's CXone is the leading CCaaS platform providing solutions such as call routing, interactive voice response, digital self-service, and workforce engagement management. Within financial crime and compliance, Nice offers risk and investigation management, fraud prevention, anti-money-laundering, and compliance solutions.

Share on Social Networks: